¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Bacterial Transferrin Receptor Complex"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
  • insulin receptor
    Àν¶¸°¼ö¿ëü
  • insulin receptor substrate-1
    Àν¶¸°¼ö¿ëü±âÁú-1
  • interferon receptor
    ÀÎÅÍÆä·Ð¼ö¿ëü
  • internalization receptor
    ³»ÀçÈ­¼ö¿ëü
  • joint receptor
    °üÀý¼ö¿ë±â
  • kinesthetic receptor
    ¿îµ¿°¨°¢¼ö¿ë±â
  • labyrinthine receptor
    ¹Ì·Î¼ö¿ë±â
  • muscarinic receptor
    ¹«½ºÄ«¸°¼ö¿ëü
  • neuromuscular receptor
    ½Å°æ±Ù(À°)¼ö¿ëü
  • nicotinic receptor
    ´ÏÄÚÆ¾¼ö¿ëü
  • olfactory receptor
    Èİ¢¼ö¿ë±â
  • opiate receptor
    ¾ÆÆíÁ¦¼ö¿ëü
  • opioid receptor
    ¾ÆÆíÀ¯»çÁ¦¼ö¿ëü
  • postsynaptic receptor
    ½Ã³À½ºÈļö¿ëü, ¿¬Á¢Èļö¿ëü
  • prejunctional receptor
    Á¢ÇÕÀü¼ö¿ëü
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
  • interferon receptor
    ÀÎÅÍÆä·Ð¼ö¿ëü
  • internalization receptor
    ³»È­¼ö¿ëü
  • irritant receptor
    Àڱؼö¿ëü
  • receptor imaging
    ¼ö¿ëü¿µ»ó, ¼ö¿ëü¿µ»óÈ­
  • receptor internalization
    ¼ö¿ëü¼¼Æ÷³»À̵¿
  • receptor-ligand interaction
    ¼ö¿ëü¹èÀ§ÀÚ»óÈ£ÀÛ¿ë
  • joint receptor
    °üÀý¼ö¿ë±â
  • kinesthetic receptor
    ¿îµ¿°¨°¢¼ö¿ëü
  • labyrinthine receptor
    ¹Ì·Î¼ö¿ëü
  • muscarinic receptor
    ¹«½ºÄ«¸°¼ö¿ëü
  • neuromuscular receptor
    ½Å°æ±ÙÀ°¼ö¿ëü
  • nicotinic receptor
    ´ÏÄÚÆ¾¼ö¿ëü
  • olfactory receptor
    Èİ¢¼ö¿ëü
  • opiate receptor
    ¾ÆÆí¼ö¿ëü
  • opioid receptor
    ¾ÆÆíÀ¯»ç¹°Áú¼ö¿ëü
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
  • receptor autoradiography
    ¼ö¿ëü ÀÚ±â¹æ»ç¼±ÃÔ¿µ¼ú
  • receptor binding
    ¼ö¿ëü°áÇÕ
  • receptor blockade
    ¼ö¿ëüÂ÷´Ü
  • receptor blocking agent
    ¼ö¿ëüÂ÷´Ü<ºÀ¼â>Á¦.
  • receptor cell
    ¼ö¿ëü ¼¼Æ÷
  • receptor destroying enzyme
    ¼ö¿ëüÆÄ±«È¿¼Ò(¡­÷òÎÕý£áÈ).
  • receptor gradient
    ¼ö¿ëü°æ»ç.
  • receptor hypothesis
    ¼ö¿ëü°¡¼³
  • receptor imaging
    ¼ö¿ëü¿µ»ó(È­)
  • receptor organ
    ¼ö¿ë±â°ü(áôé»Ðïί).
  • receptor potential
    ¼ö¿ë±âÀüÀ§.
  • receptor sensitivity
    ¼ö¿ëü °¨¼ö¼º
  • receptor site
    ¼ö¿ëüºÎÀ§.
  • receptor stimulants
    ¼ö¿ëüÀÚ±ØÁ¦.
  • receptor supersensitivity
    ¼ö¿ëü Ãʰ¨¼ö¼º(áôéÄô÷ õ±Êïáôàõ)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
  • recurrent bacterial meningitis
    Àç¹ß¼º ¼¼±Õ¼º ¼ö¸·¿°(î¢Û¡àõá¬Ð¶àõâÐØ¯æú)
  • secondary bacterial infection
    ÀÌÂ÷¼¼±Õ°¨¿°
  • subacute bacterial endocarditis
    ¾Æ±Þ¼º ¼¼±Õ¼º½É³»¸·¿°
  • subacute bacterial endocarditis
    ¾Æ±Þ¼º¼¼±Õ¼º½É³»¸·¿°(ä¬Ðáàõá¬Ð¶àõ ãýҮدæú)
  • subacute bacterial endocarditis
    ¾Æ±Þ¼º ¼¼±Õ¼º ½É³»¸·¿°.
  • thermophilic bacterial digestion
    °í¿Â±ÕºÎÆÐ(¡­Ý¯ø¨).
  • total bacterial count
    Ãѱռö
  • virus, bacterial
    ¼¼±Õ¹ÙÀÌ·¯½º, ¹ÚÅ׸®¿ÀÆÄÁö
  • activated complex
    Ȱ¼ºº¹ÇÕ, Ȱ¼ºº¹ÇÕ¹°
  • acyl-plasminogen streptokinase activator complex
    ¾Æ½Ç-Çø®Áî¹Ì³ë°Õ½ºÆ®·¾ÅäŰ³ªÁ¦È°¼ºÁ¦º¹ÇÕü
  • agr complex
    AGR º¹ÇÕü(¡­ÜÜùêô÷)
  • amylase complex with immunoglobulin = macroamylase
    ¸é¿ª±ÛºÒ¸°¾Æ¹Ð¶óÁ¦º¹ÇÕü=¸¶Å©·Î¾Æ¹Ð¶óÁ¦
  • anti-inhibitor coagulation complex
    Ç×¾ïÁ¦Á¦ÀÀ°í°áÇÕü
  • antigen-antibody complex
    Ç׿ø-Ç×üº¹ÇÕü
  • antigen-antibody complex, soluble
    ¼ö¿ë¼º Ç׿ø-Ç×üº¹ÇÕü
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 6 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
  • synaptonemal complex
    ½Ã³³Å伨 º¹ÇÕü(ÜÜùêô÷)
  • ternary complex mechanism
    »ï¼ººÐº¹ÇÕü ±âÀü (ß²à÷ÝÂÜÜùêô÷Ѧï®)
  • ternary complex model
    »ï¼ººÐº¹ÇÕü (ß²à÷ÝÂÜÜùêô÷)¸ðµ¨
  • transitory complex
    õÀ̺¹ÇÕü(ôÃì¹ÜÜùêô÷)
  • van't Hoff complex
    ¹ÝÆ® È£ÇÁ º¹ÇÕü (ÜÜùêô÷)
  • vitamin B complex
    ºñŸ¹Î B º¹ÇÕü (ÜÜùêô÷)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 7
BE   1) Bacterial Endocarditis
  2) Base Excess
  3) Below the Elbo...
BV   1) Blood Volume
  2) Bacterial Vaginosis
NBTE Non-Bacterial Thrombotic Endocarditis
SBE Subacute Bacterial Endocarditis; ¾Æ±Þ¼º ¼¼±Õ¼º ½É³»¸·¿°
SBP Spontaneous Bacterial Peritonitis
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 7
TCR T cell antigen receptor complex
GRC glucocorticoid receptor complex
CRLR Calcitonin Receptor-Like Receptor
EGF-receptor Epidermal Growth Factor receptor
IRR Insulin receptor- related receptor
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • drug-induced immune complex
    ¾àÁ¦ À¯¹ß¼º ¸é¿ª º¹ÇÕü
  • ego-alien complex
    ÀÚ¾Æ ÀÌÁú ÄÄÇ÷º½º
  • electra complex
    ¿¤·ºÆ®¶ó ÄÞÇ÷º½º
    ÇÁ·ÎÀ̵åÀÇ ¼º°Ý ±¸Á¶·ÐÀÇ ¹ß´Þ ´Ü°è Áß ³²±Ù±âÀÎ 3¼¼¿¡¼­ 6¼¼ »çÀÌÀÇ ¿©ÀÚ ¾ÆÀ̰¡ ¾î¸Ó´Ï¸¦ ¾Æ¹öÁöÀÇ ¼ºÀû °ü½ÉÀÇ °æÀïÀÚ·Î º¸°Ô µÇ°í ¾î¸Ó´Ï¸¦ µÎ·Á¿öÇÏ°Ô µÇ¾î ¾î¸Ó´Ï¸¦ ¹è°ÝÇÏ°í ¾Æ¹öÁö¸¦ »ç¸ðÇÏ´Â Çö»óÀ¸·Î ¾î¸Ó´Ï¿ÍÀÇ µ¿ÀϽð¡ ¿©¾ÆÀÇ ºÒ¾ÈÀ» ÇØ°áÇØ ÁÖ´Â °ÍÀ¸·Î º¸ÀδÙ.
  • immune complex
    ¸é¿ª º¹ÇÕü
    Ç׿ø°ú Ç×üÀÇ Æ¯Á¤ °áÇÕ¹°. ¹ÙÀÌ·¯½º³ª ¼¼±Õ µî À̹°ÀÇ Ä¨ÀÔ¿¡ ´ëÇØ¼­ »ýü°¡ »ý»êÇÑ Ç×ü´Â À̹°ÀÎ Ç׿ø°ú °áÇÕÇÏ¿© ¸é¿ª º¹ÇÕü¸¦ ¸¸µç´Ù. À̴ Ž½Ä ¼¼Æ÷³ª º¸Ã¼¸¦ Ȱ¼ºÈ­ÇÏ¿© À̹°ÀÌ ¹«ÇØÇÑ °ÍÀ¸·Î ºÐÇØÇÏ´Â °ÍÀ» µµ¿Í »ýü ¹æ¾î¿¡ µµ¿òÀ» ÁØ´Ù. Á¶Á÷ Àå¾ÖÀûÀ¸·Î ÀÛ¿ëÇÏ¿© ¸é¿ª º¹ÇÕ¼º ÁúȯÀ» ÀÏÀ¸Å°±âµµ ÇÑ´Ù.
  • immune complex-mediated
    ¸é¿ª º¹ÇÕü ¸Å°³¼º
  • intralaminar complex
    Ãþ³» º¹ÇÕü
  • major histocompatibility complex
    ÁÖ Á¶Á÷ ÀûÇÕü, ÁÖ Á¶Á÷ ÀûÇÕ º¹ÇÕü
    ÀÎü Á¶Á÷ÇüÀ» °áÁ¤ÇÏ´Â À¯ÀüÀÚ°¡ 6¹ø ¿°»öüÀÇ ÀÛÀº ºÐÀý¿¡ º¹ÇÕü¸¦ Çü¼ºÇϰí À־ ÀÌ À¯ÀüÀÚ ¿µ¿ªÀ» À̸£´Â ¿ë¾î.
  • mother, complex
    ¸ð º¹ÇÕü
  • complex neutrocclusion
    º¹ÇÕ Áß¼º ±³ÇÕ
    ¾È¸ð¿Í º¹ÀâÇÑ ±³Á¤ Ä¡·á¸¦ µ¿¹ÝÇÏ´Â Áß¼º ±³ÇÕ.
  • nasomaxillary complex
    ºñ »ó¾Ç º¹ÇÕü
  • nitrogenase complex
    Áú¼Ò °íÁ¤ È¿¼Ò º¹ÇÕü
  • Oedipus complex
    ¿ÀÀ̵ðǪ½º ÄÞÇ÷º½º
    ÇÐ·É Àü±â ¾Æµ¿ÀÌ ¹Ý´ë¼ºÀÇ ºÎ¸ð¸¦ È¥ÀÚ¼­ ¼ÒÀ¯ÇÏ°í ½ÍÀº ¿å¸ÁÀ» °¡Áö¸ç, °°Àº ¼ºÀÇ ºÎ¸ð¿¡°Ô °æÀï Àǽİú ÁúÅõ ÀǽÄÀ» °®°Ô µÇ´Â ½É¸®Àû Çö»ó.
  • olivary complex
    ¿Ã¸®ºê º¹ÇÕü
  • protein-drug complex
    ´Ü¹é-¾à¹° º¹ÇÕü
  • self-associated rheumatoid factor complex

    self-care (ÀÚ°¡ Ä¡·á

CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 7
gene rearrangement, alpha-chain T-cell antigen receptor Ordered rearrangement of T-cell variable gene regions coding for the alpha-chain of antigen receptors.
(12 Dec 1998)
gene rearrangement, beta-chain T-cell antigen receptor Ordered rearrangement of T-cell variable gene regions coding for the beta-chain of antigen receptors.
(12 Dec 1998)
gene rearrangement, delta-chain T-cell antigen receptor Ordered rearrangement of T-cell variable gene regions coding for the delta-chain of antigen receptors.
(12 Dec 1998)
gene rearrangement, gamma-chain T-cell antigen receptor Ordered rearrangement of T-cell variable gene regions coding for the gamma-chain of antigen receptors.
(12 Dec 1998)
genes, T-cell receptor DNA sequences, in cells of the t-lymphocyte lineage, that code for T-cell receptors. The tcr genes are formed by somatic rearrangement (see gene rearrangement, t-lymphocyte and its children) of germline gene segments, and resemble ig genes in their mechanisms of diversity generation and expression.
(12 Dec 1998)
genes, T-cell receptor alpha DNA sequences encoding the alpha chain of the T-cell receptor. The genomic organization of the tcr alpha genes is essentially the same in all species and is similar to the organization of ig genes.
(12 Dec 1998)
genes, T-cell receptor beta DNA sequences encoding the beta chain of the T-cell receptor. The genomic organization of the tcr beta genes is essentially the same in all species and is similar to the organization of ig genes.
(12 Dec 1998)
genes, T-cell receptor delta DNA sequences encoding the delta chain of the T-cell receptor. The delta-chain locus is located entirely within the alpha-chain locus.
(12 Dec 1998)
genes, T-cell receptor gamma DNA sequences encoding the gamma chain of the T-cell receptor. The human gamma-chain locus is organised similarly to the tcr beta-chain locus.
(12 Dec 1998)
receptor 1. A molecular structure within a cell or on the surface characterised by selective binding of a specific substance and a specific physiologic effect that accompanies the binding, for example, cell surface receptors for peptide hormones, neurotransmitters, antigens, complement fragments and immunoglobulins and cytoplasmic receptors for steroid hormones.
2. A sensory nerve terminal that responds to stimuli of various kinds.
(18 Nov 1997)
receptor aggregation Chemically stimulated aggregation of cell surface receptors, which potentiates the action of the effector cell.
(12 Dec 1998)
receptor agonist A substance that mimics a specificneurotransmitter, is able to attach to that neurotransmitter's receptor and thereby produces the same action that theneurotransmitter usually produces. Drugs are often designed as receptor agonists to treat a variety of diseases and disorders whenthe original chemical substance is missing or depleted.
(22 May 1997)
receptor, chemokine A molecule that receives a chemokine and acts as a dock for a chemokine. Several chemokine receptors are essential co-receptors for HIV.
(12 Dec 1998)
receptor downregulation A phenomenon observed in many cells: following stimulation with a ligand the number of receptors for that ligand on the cell surface diminishes because internalisation exceeds replenishment. Often used very loosely, thus destroying the utility of the term.
(18 Nov 1997)
receptor mediated endocytosis Endocytosis of molecules by means of a specific receptor protein that normally resides in a coated pit, but may enter this structure after complex formation occurs. The structure then forms a coated vesicle that delivers its contents to the endosome whence it may enter the cytoplasm or the lysosomal compartment. Many bacterial toxins and viruses enter cells by this route.
(18 Nov 1997)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 7
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 7
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 7
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 7
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 7
ÅëÇÕ°Ë»ö ¿Ï·á